ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: In the mild NAFLD disease subgroup, no significant difference in circulating ANGPTL8 levels was noted compared to the controls (Standardized Mean Difference, SMD = 0.43, 95% CI: -3.55, 4.42, p = 0.40; I2 = 41%).